Aligos Therapeutics, Inc. · NASDAQ:ALGS
Sio Capital Management, LLC reported a 5.49% stake in Aligos Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 13, 2025
Sio Capital Management, LLC reported a 5.49% stake in Aligos Therapeutics, Inc., 355,937 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G).
- Stake
- 5.49%
- Shares
- 355,937
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sio Capital Management, LLC | 5.49% | 355,937 |
Source
Related
- Aligos Therapeutics, Inc.
- Sio Capital Management, LLC
- Aligos Therapeutics, Inc. shareholders
- Schedule 13G/A · Sio Capital Management, LLC · Feb 11, 2026
- Schedule 13D · Lawrence M. Blatt · Jun 24, 2026
- Schedule 13G/A · Woodline Partners LP · May 15, 2026
- Schedule 13G · Lawrence M. Blatt · May 15, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Woodline Partners LP · Nov 14, 2025